Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$14.14 - $23.06 $2,828 - $4,612
-200 Reduced 25.0%
600 $10,000
Q3 2022

Oct 25, 2022

SELL
$13.05 - $22.13 $103,199 - $175,004
-7,908 Reduced 90.81%
800 $11,000
Q2 2022

Aug 04, 2022

SELL
$12.26 - $31.17 $59,436 - $151,112
-4,848 Reduced 35.76%
8,708 $137,000
Q1 2022

Apr 14, 2022

BUY
$17.64 - $39.57 $210,586 - $472,386
11,938 Added 737.82%
13,556 $365,000
Q4 2021

Jan 18, 2022

BUY
$34.2 - $47.56 $25,000 - $34,766
731 Added 82.41%
1,618 $59,000
Q3 2021

Oct 26, 2021

SELL
$27.88 - $58.25 $56,122 - $117,257
-2,013 Reduced 69.41%
887 $42,000
Q2 2021

Jul 19, 2021

BUY
$25.79 - $42.11 $61,019 - $99,632
2,366 Added 443.07%
2,900 $98,000
Q1 2021

Apr 26, 2021

SELL
$38.75 - $86.92 $386,182 - $866,244
-9,966 Reduced 94.91%
534 $22,000
Q4 2020

Jan 21, 2021

BUY
$34.61 - $123.66 $166,058 - $593,320
4,798 Added 84.15%
10,500 $455,000
Q3 2020

Oct 27, 2020

BUY
$37.49 - $63.19 $69,881 - $117,786
1,864 Added 48.57%
5,702 $244,000
Q2 2020

Jul 22, 2020

BUY
$12.66 - $58.27 $35,929 - $165,370
2,838 Added 283.8%
3,838 $179,000
Q1 2020

May 07, 2020

SELL
$9.31 - $18.26 $1,862 - $3,652
-200 Reduced 16.67%
1,000 $13,000
Q4 2019

Feb 06, 2020

BUY
$8.93 - $12.41 $3,572 - $4,964
400 Added 50.0%
1,200 $13,000
Q3 2019

Oct 28, 2019

SELL
$8.8 - $14.5 $880 - $1,450
-100 Reduced 11.11%
800 $8,000
Q2 2019

Aug 09, 2019

BUY
$5.78 - $9.79 $5,202 - $8,811
900 New
900 $8,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $411M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.